1.上海中医药大学附属龙华医院神经外科(上海 200032)
2.上海中医药大学脊柱病研究所(上海 201210)
3.上海中医药大学附属龙华医院脑病科(上海 200032)
王永谦,男,博士,副主任医师,主要从事脑血管病中西医结合治疗的临床研究
扫 描 看 全 文
王永谦, 冯庆琪, 张征达, 等. 中药益气化瘀方对慢性硬膜下血肿术后颅内残余血肿影响的临床研究[J]. 上海中医药杂志, 2021,55(1):61-65.
Yongqian WANG, Qingqi FENG, Zhengda ZHANG, et al. Clinical study on the effect of Yiqi Huayu Decoction on intracranial residual hematoma after chronic subdural hematoma surgery[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(1):61-65.
王永谦, 冯庆琪, 张征达, 等. 中药益气化瘀方对慢性硬膜下血肿术后颅内残余血肿影响的临床研究[J]. 上海中医药杂志, 2021,55(1):61-65. DOI: 10.16305/j.1007-1334.2021.1907171.
Yongqian WANG, Qingqi FENG, Zhengda ZHANG, et al. Clinical study on the effect of Yiqi Huayu Decoction on intracranial residual hematoma after chronic subdural hematoma surgery[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(1):61-65. DOI: 10.16305/j.1007-1334.2021.1907171.
目的,2,观察中药益气化瘀方治疗慢性硬膜下血肿钻颅引流手术术后颅内残余血肿的临床疗效。,方法,2,将56例慢性硬膜下血肿患者随机分为治疗组(33例)及对照组(23例)。两组均采用钻颅引流术,术后治疗组予中药益气化瘀方治疗,对照组予阿托伐他汀片治疗。两组连续服药直至残余血肿完全吸收或体积显著减少(体积≤10 cm,3,),至少连续服药30 d。,结果,2,①试验期间共有2例病例脱落,其中治疗组1例,对照组1例。②术前与术后各时点组内比较,两组残余血肿体积差异均有统计学意义(,P,<,0.05),术后7 d与术后14 d、30 d、60 d、180 d比较,残余血肿体积缩小率差异均有统计学意义(,P,<,0.05)。组间术后60 d、180 d残余血肿体积比较,治疗组明显小于对照组(,P,<,0.05),组间术后30 d、60 d、180 d残余血肿体积缩小率比较,治疗组明显高于对照组(,P,<,0.05)。③随访期间,治疗组和对照组残余血肿复发率分别为3.1%(1/32)和13.6%(3/22),差异无显著性意义(,P,>,0.05)。④经Logistic回归分析,提示高龄(,>,80岁)和术后较小的血肿体积缩小率(,<,30%)与血肿复发密切相关(,P,=0.008 和 ,P,=0.011)。⑤术前与术后各时点组内比较,两组改良Rankin评分均明显下降(,P,<,0.05)。组间术后相同时点比较,改良Rankin评分差异无统计学意义(,P,>,0.05)。⑥两组不良反应发生率比较,差异无统计学意义(,P,>,0.05)。,结论,2,与阿托伐他汀片相比,中药益气化瘀方治疗钻颅引流手术术后慢性硬膜下血肿患者,可更好地促进术后残余血肿的吸收;同时该中药疗法不良反应少,还可改善患者术后的神经功能。
Objective,2,To observe the clinical effect of Yiqi Huayu Decoction on intracranial residual hematoma after burr hole drainage surgery of chronic subdural hematoma (CSDH).,Methods,2,A total of 56 patients with chronic subdural hematoma were randomly divided into treatment group (,n,=33) and control group (,n,=23). Both groups conducted burr hole drainage surgery. After surgery, the treatment group was treated with Yiqi Huayu Decoction, while the control group was treated with atorvastatin tablets. The two groups were administered corresponding medicine continuously for at least 4 weeks until the residual hematoma was completely absorbed or the volume significantly reduced (,V,≤10 cm,3,).,Results,2,①During the follow-up period, there were 2 dropout cases, including 1 case in the treatment group and 1 case in the control group. ②The differences in the volume of residual hematoma were significant (,P,<,0.05) when comparing the volume before operation and that at each time point after operation in both groups. The differences in the volume reduction rate of residual hematoma were significant statistically when comparing the reduction rate on day 7 after operation and that on day 14, day 30, day 60 and day 180 respectively after operation in both groups (,P,<,0.05). The volume of residual hematoma in the treatment group was significantly smaller than that in the control group on day 60 and day 180 after operation (,P,<,0.05), and the volume reduction rate of residual hematoma in the treatment group was significantly higher than that in the control group on day 30, day 60 and day 180 after operation (,P,<,0.05). ③During the follow-up period, the recurrence rates of residual hematoma in the treatment group and the control group were 3.1% (1/32) and 13.6% (3/22), respectively, with no significant difference (,P,>,0.05). ④Logistic regression analysis showed that the old age (,>,80 years old) and the smaller hematoma volume reduction rate after operation (,<,30%) were closely related to hematoma recurrence (,P,=0.008,P,=0.01). ⑤The modified Rankin score of the two groups decreased significantly before and after operation (,P,<,0.05). There was no significant difference in modified Rankin score between groups at each time point after operation (,P,>,0.05). ⑥There was no significant difference in the incidence of adverse reactions between the two groups (,P,>,0.05).,Conclusion,2,Compared with atorvastatin tablets, Yiqi Huayu Decoction can better promote the absorption of residual hematoma after burr hole drainage surgery in patients with chronic subdural hematoma. Meanwhile, without severe adverse reactions, Yiqi Huayu Decoction can also improve the postoperative neurological function of patients.
慢性硬膜下血肿老年人钻颅引流术中医疗法颅内残余血肿术后复发神经功能
chronic subdural hematomathe elderlyburr hole drainage surgerytraditional Chinese medicine therapyintracranial residual hematomarecurrence after operationneurological function
VAMOTO H S,LEMOS JR H P,ATALLAH A N.Surgical treatments for chronic subdural hematomas: a comprehensive systematic review[J].World Neursurg,2016(86):399-418.
宋直昇,王拥军,施杞.施杞治疗慢性硬脑膜下血肿经验[J].中医杂志,2013,54(14):1189-1191.
曹德茂,陆彦沁,齐文涛,等.阿托伐他汀在慢性硬膜下血肿治疗中的研究进展[J].中华危重症医学杂志,2017,10(5):352-356.
王忠诚.神经外科学[M].武汉:湖北科学技术出版社,2011:3,442-443.
国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:219.
许汝福,尹全焕.各组例数不等的完全随机区段分组法[J].中国卫生统计,1993,10(5):45-46.
范玉华,姬晓昙,蓝琳芳.国内脑卒中临床试验疗效判断方法中改良Rankin评分的应用现状[J].中国神经精神疾病杂志,2015,41(7):412-415.
BERGHAUSER P L M,DAMMERS R,SCHOUTEN J W,et al.Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on preoperative corticosteroid therapy[J].Neurosurgery,2012,70(4):873-880.
黄立航,黄柒金,蔡志强.醒脑静联合阿托伐他汀钙治疗慢性硬膜下血肿的疗效观察[J].中国微侵袭神经外科杂志,2017,22(12):548-550.
ALMENAWER S A,FARROKHYAR F,HONG C,et al.Chronic subdural hematoma management:a systematic review and meta-analysis of 34829 patients[J].Ann Surg,2014,259(3):449-457.
谢才军,张志强,涂常飞,等.活血化瘀法治疗老年慢性硬膜下血肿疗效观察[J].新中医,2017,49(11):32-34.
杨丰文,吴琼慧,邹佳涵,等.中药抗炎临床研究的可视化分析[J].中国药物评价,2018,35(2):135-140.
陈健.脑出血急性期活血化瘀药物应用的研究现状与展望[J].中西医结合心脑血管病杂志,2018,16(3):305-308.
王殿海,耿维,李成建.药物联用所致横纹肌溶解症文献概述[J].中国药物滥用防治杂志,2017,23(1):52-53.
0
浏览量
185
下载量
0
CSCD
9
CNKI被引量
关联资源
相关文章
相关作者
相关机构